Youjin Kim1, Tianxiao Huan2, Roby Joehanes3, Nicola M McKeown1,4, Steve Horvath5,6, Daniel Levy3, Jiantao Ma1. 1. Nutrition Epidemiology and Data Science, Friedman School of Nutrition Science and Policy, Tufts University, Boston, MA, USA. 2. Department of Ophthalmology and Visual Sciences, University of Massachusetts Medical School, Worcester, MA, USA. 3. Population Sciences Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD & Framingham Heart Study, Framingham, MA, USA. 4. Nutritional Epidemiology Laboratory, Jean Mayer USDA Human Nutrition Research Center on Aging, Tufts University, Boston, MA, USA. 5. Department of Human Genetics, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, USA. 6. Department of Biostatistics, Fielding School of Public Health, University of California Los Angeles, Los Angeles, CA, USA.
Abstract
BACKGROUND: DNA methylation-based epigenetic age measures have been used as biological aging markers and are associated with a healthy lifespan. Few population-based studies have examined the relation between diet and epigenetic age acceleration. OBJECTIVES: We aimed to investigate the relation between diet quality and epigenetic age acceleration. METHODS: We analyzed data from 1995 participants (mean age, 67 years; 55% women) of the Framingham Heart Study Offspring Cohort. Cross-sectional associations between the Dietary Approaches to Stop Hypertension (DASH) score and 3 whole-blood DNA methylation-derived epigenetic age acceleration measures-Dunedin Pace of Aging Methylation (DunedinPoAm), GrimAge acceleration (GrimAA), and PhenoAge acceleration (PhenoAA)-were examined. A mediation analysis was conducted to assess the mediating role of epigenetic age acceleration in relation to DASH and all-cause mortality. RESULTS: A higher DASH score was associated with lower levels of DunedinPoAm (β = -0.05; SE = 0.02; P = 0.007), GrimAA (β = -0.09; SE = 0.02; P < 0.001), and PhenoAA (β = -0.07; SE = 0.02; P = 0.001). All 3 epigenetic measures mediated the association between the DASH score and all-cause mortality, with mean proportions of 22.1% for DunedinPoAm (Pmediation = 0.04), 45.1% for GrimAA (Pmediation = 0.001), and 22.9% for PhenoAA (Pmediation = 0.03). An interaction was observed between the DASH score and smoking status in relation to the epigenetic aging markers. The association between the DASH score and epigenetic aging markers tended to be stronger in "ever-smokers" (former and current smokers) compared to "never-smokers." The proportions of mediation were 31.3% for DunedinPoAm, 46.8% for GrimAA, and 10.3% for PhenoAA in ever-smokers, whereas no significant mediation was observed in never-smokers. CONCLUSIONS: Higher diet quality is associated with slower epigenetic age acceleration, which partially explains the beneficial effect of diet quality on the lifespan. Our findings emphasize that adopting a healthy diet is crucial for maintaining healthy aging.
BACKGROUND: DNA methylation-based epigenetic age measures have been used as biological aging markers and are associated with a healthy lifespan. Few population-based studies have examined the relation between diet and epigenetic age acceleration. OBJECTIVES: We aimed to investigate the relation between diet quality and epigenetic age acceleration. METHODS: We analyzed data from 1995 participants (mean age, 67 years; 55% women) of the Framingham Heart Study Offspring Cohort. Cross-sectional associations between the Dietary Approaches to Stop Hypertension (DASH) score and 3 whole-blood DNA methylation-derived epigenetic age acceleration measures-Dunedin Pace of Aging Methylation (DunedinPoAm), GrimAge acceleration (GrimAA), and PhenoAge acceleration (PhenoAA)-were examined. A mediation analysis was conducted to assess the mediating role of epigenetic age acceleration in relation to DASH and all-cause mortality. RESULTS: A higher DASH score was associated with lower levels of DunedinPoAm (β = -0.05; SE = 0.02; P = 0.007), GrimAA (β = -0.09; SE = 0.02; P < 0.001), and PhenoAA (β = -0.07; SE = 0.02; P = 0.001). All 3 epigenetic measures mediated the association between the DASH score and all-cause mortality, with mean proportions of 22.1% for DunedinPoAm (Pmediation = 0.04), 45.1% for GrimAA (Pmediation = 0.001), and 22.9% for PhenoAA (Pmediation = 0.03). An interaction was observed between the DASH score and smoking status in relation to the epigenetic aging markers. The association between the DASH score and epigenetic aging markers tended to be stronger in "ever-smokers" (former and current smokers) compared to "never-smokers." The proportions of mediation were 31.3% for DunedinPoAm, 46.8% for GrimAA, and 10.3% for PhenoAA in ever-smokers, whereas no significant mediation was observed in never-smokers. CONCLUSIONS: Higher diet quality is associated with slower epigenetic age acceleration, which partially explains the beneficial effect of diet quality on the lifespan. Our findings emphasize that adopting a healthy diet is crucial for maintaining healthy aging.
Authors: Mercedes Sotos-Prieto; Shilpa N Bhupathiraju; Josiemer Mattei; Teresa T Fung; Yanping Li; An Pan; Walter C Willett; Eric B Rimm; Frank B Hu Journal: N Engl J Med Date: 2017-07-13 Impact factor: 91.245
Authors: Craig R Walsh; Martin G Larson; Jane C Evans; Luc Djousse; R Curtis Ellison; Ramachandran S Vasan; Daniel Levy Journal: Ann Intern Med Date: 2002-02-05 Impact factor: 25.391
Authors: Greta Lee Splansky; Diane Corey; Qiong Yang; Larry D Atwood; L Adrienne Cupples; Emelia J Benjamin; Ralph B D'Agostino; Caroline S Fox; Martin G Larson; Joanne M Murabito; Christopher J O'Donnell; Ramachandran S Vasan; Philip A Wolf; Daniel Levy Journal: Am J Epidemiol Date: 2007-03-19 Impact factor: 4.897
Authors: Teresa T Fung; Stephanie E Chiuve; Marjorie L McCullough; Kathryn M Rexrode; Giancarlo Logroscino; Frank B Hu Journal: Arch Intern Med Date: 2008-04-14
Authors: Eugene Andres Houseman; William P Accomando; Devin C Koestler; Brock C Christensen; Carmen J Marsit; Heather H Nelson; John K Wiencke; Karl T Kelsey Journal: BMC Bioinformatics Date: 2012-05-08 Impact factor: 3.169
Authors: Jiantao Ma; Casey M Rebholz; Kim V E Braun; Lindsay M Reynolds; Stella Aslibekyan; Rui Xia; Niranjan G Biligowda; Tianxiao Huan; Chunyu Liu; Michael M Mendelson; Roby Joehanes; Emily A Hu; Mara Z Vitolins; Alexis C Wood; Kurt Lohman; Carolina Ochoa-Rosales; Joyce van Meurs; Andre Uitterlinden; Yongmei Liu; Mohamed A Elhadad; Margit Heier; Melanie Waldenberger; Annette Peters; Elena Colicino; Eric A Whitsel; Antoine Baldassari; Sina A Gharib; Nona Sotoodehnia; Jennifer A Brody; Colleen M Sitlani; Toshiko Tanaka; W David Hill; Janie Corley; Ian J Deary; Yan Zhang; Ben Schöttker; Hermann Brenner; Maura E Walker; Shumao Ye; Steve Nguyen; Jim Pankow; Ellen W Demerath; Yinan Zheng; Lifang Hou; Liming Liang; Alice H Lichtenstein; Frank B Hu; Myriam Fornage; Trudy Voortman; Daniel Levy Journal: Circ Genom Precis Med Date: 2020-06-11
Authors: Marguerite R Irvin; Stella Aslibekyan; Anh Do; Degui Zhi; Bertha Hidalgo; Steven A Claas; Vinodh Srinivasasainagendra; Steve Horvath; Hemant K Tiwari; Devin M Absher; Donna K Arnett Journal: Clin Epigenetics Date: 2018-04-18 Impact factor: 6.551
Authors: Kyeezu Kim; Yinan Zheng; Brian T Joyce; Hongmei Jiang; Philip Greenland; David R Jacobs; Kai Zhang; Lei Liu; Norrina B Allen; John T Wilkins; Sarah N Forrester; Donald M Lloyd-Jones; Lifang Hou Journal: Clin Epigenetics Date: 2022-07-07 Impact factor: 7.259
Authors: Adiv A Johnson; Bradley W English; Maxim N Shokhirev; David A Sinclair; Trinna L Cuellar Journal: Aging Cell Date: 2022-07-02 Impact factor: 11.005